Black Diamond Therapeutics (BDTX)
NASDAQ:BDTX
US Market
Holding BDTX?
Track your performance easily

Black Diamond Therapeutics (BDTX) Financial Statements

768 Followers

Black Diamond Therapeutics Financial Overview

Black Diamond Therapeutics's market cap is currently ―. The company's EPS TTM is $-1.54; its P/E ratio is -3.07; Black Diamond Therapeutics is scheduled to report earnings on November 4, 2024, and the estimated EPS forecast is $-0.34. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 615.00K$ 456.00K$ 334.00K$ 334.00K$ 335.00K
Gross Profit$ 615.00K$ 456.00K$ 334.00K$ 334.00K$ 335.00K
EBIT$ -19.91M$ -18.23M$ -19.41M$ -23.01M$ -19.15M
EBITDA$ -19.82M$ -18.14M$ -19.32M$ -22.89M$ -19.04M
Net Income Common Stockholders$ -19.91M$ -18.23M$ -19.41M$ -23.01M$ -19.15M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 122.97M$ 115.20M$ 131.40M$ 144.26M$ 89.53M
Total Assets$ 149.99M$ 142.52M$ 158.57M$ 172.38M$ 119.88M
Total Debt$ 20.53M$ 21.36M$ 22.18M$ 23.00M$ 23.78M
Net Debt$ -102.44M$ -93.84M$ -109.22M$ -121.26M$ -65.75M
Total Liabilities$ 38.97M$ 38.22M$ 41.83M$ 38.06M$ 37.68M
Stockholders Equity$ 110.99M$ 104.31M$ 116.74M$ 134.32M$ 82.20M
Cash Flow-
Free Cash Flow$ -14.69M$ -21.20M$ -13.96M$ -18.39M$ -14.27M
Operating Cash Flow$ -14.73M$ -21.20M$ -13.96M$ -18.36M$ -14.37M
Investing Cash Flow$ 740.00K$ -13.73M$ 12.25M$ -37.88M$ 17.18M
Financing Cash Flow$ 21.38M$ 4.13M$ -46.00K$ 71.93M-
Currency in USD

Black Diamond Therapeutics Earnings and Revenue History

Black Diamond Therapeutics Debt to Assets

Black Diamond Therapeutics Cash Flow

Black Diamond Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis